MedTrace Logo

A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil

NCT01108900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-02-01

No results posted yet for this study

Summary

In the present study, it is planned to observe a population of 100 ED patients treated previously with udenafil and for whom their physician decided to switch them to sildenafil because of poor udenafil tolerance and/or poor efficacy.

Conditions

Interventions

DRUG

sildenafil

tables, 25,50,100 mg, on demand, 1 month

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01108900 on ClinicalTrials.gov